Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Gilead To License HCV Drug In Bid To Improve Access In Lower-Income Countries

News outlets report on Gilead’s agreement with Indian generic drugmakers to allow production of its hepatitis C medication. Financial Times: Gilead in deal with India labs to produce Sovaldi “Gilead Sciences will allow seven large Indian generic drug producers to make and sell its blockbuster hepatitis C drug Sovaldi in…

First British Volunteer Receives Experimental Ebola Vaccine

News outlets report on the announcement that the first British volunteer was injected this week with an experimental Ebola vaccine, made by GlaxoSmithKline and the U.S. National Institutes of Health. Associated Press: 1st U.K. volunteer gets experimental Ebola vaccine “British scientists say a former nurse has become the first person…

NIH Experimental Ebola Vaccine Trial Begins; Other Vaccines, Treatments Under Development

News outlets report on various aspects of Ebola vaccine and treatment development and delivery. ABC News: Two Women Receive Experimental Ebola Vaccine in Fast-Tracked Trial “The first two doses of an experimental Ebola vaccine have been injected into human subjects in the National Institutes of Health’s fast-tracked clinical trial…” (Lupkin,…

USAID To Invest $6.3M In Public-Private Partnerships To Boost Impact Investing

Thomson Reuters Foundation: U.S. boosts public-private partnerships to grow impact investing “The United States on Thursday announced three public-private partnerships to boost private investment in early-stage enterprises in developing countries as part of its strategy to make impact investing and private sector partnerships a backbone of its development policy. The…

New PPP Focuses On Strengthening HIV/AIDS Lab Systems In Sub-Saharan Africa

Siemens Healthcare: New Public-Private Partnership Uses E-Learning to Fight HIV/AIDS “…[On Monday,] at the 2014 Clinton Global Initiative (CGI) Annual Meeting, Siemens Healthcare, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), and the U.S. Centers for Disease Control and Prevention (CDC) announced ‘Stronger Together,’ a new five-year Commitment to…

Denmark, Netherlands Launch Fund To Support Sexual, Reproductive Health Groups

The Guardian: Denmark and Netherlands launch fund for sexual health groups “A €15m (£12m) fund to support small, grassroots organizations that are defending sexual and reproductive health and rights was launched in New York on Monday. The Amplify Change fund, financed by the Danish and Dutch governments, along with the…

AfDB Chief Urges Businesses To Step Forward In Ebola Efforts

Reuters: Time for business to get involved in Africa Ebola battle — AfDB chief “West African nations hit by the Ebola virus epidemic will need international help to rebuild for years to come and it is time for mining companies and business to get involved, the head of the African…

U.N. Discusses SDGs; Report Estimates Goal Monitoring To Cost $250B

News outlets report on the U.N.’s discussions surrounding the post-2015 development agenda and a new report estimating development goal monitoring will cost $250 billion. GlobalPost: At U.N. General Assembly, global health projects are big business “…While it is clear that the eight goals will not be met by the December…

Blog Posts Discuss Issues Surrounding Ebola Outbreak

Several blogs published pieces discussing various issues related to the Ebola outbreak. Center for Global Development’s “Global Health Policy Blog”: Aversion Behavior Exacerbates the Economic Impact of Ebola Mead Over, senior fellow at CGD, discusses a World Bank report that examines the economic impact of Ebola on affected West African…

GSK Experimental Ebola Vaccine Soon To Be Tested In Humans

News outlets report on GlaxoSmithKline’s (GSK) plans to test its experimental Ebola vaccine in humans. Bloomberg News: Glaxo’s Ebola Vaccine to Be Tested for Safety in Humans “U.S. scientists will begin enrolling patients as soon as next week in clinical safety trials of GlaxoSmithKline Plc (GSK)’s experimental Ebola vaccine as…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.